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RESEARCH ARTICLE
Drug-Resistant Epilepsy in Children with Juvenile
Huntington’s Disease: A Challenging Case and Brief
Review
Abdulhafeez M. Khair MD1, Jessica Kabrt DO2, Stephen Falchek MD3
ABSTRACT
Huntington’s Disease (HD) is an autosomal dominant
neurodegenerative disorder with a progressive decline
in cognitive, motor, and psychological function.
Chorea tends to be the most common associated
movement disorder, although other variants of
several abnormal movements are also seen. Adult-
onset HD is the most common subtype. Juvenile
Huntington’s disease (JHD) accounts for 5%–10% of
all HD cases and presents as a rapidly progressive
disorder with a multitude of characteristics. We report
on a 9-year-old male with JHD who presented with
refractory epilepsy. His EEG findings, seizure type, and
antiepileptic drug usage are discussed with a brief
review of the currently available relevant literature.
The currently reported case sheds light on anti-
epileptic drugs that proved effective in our patient
and the importance of screening for JHD when a child
presents with seizures that are difficult to control.
Keywords: Huntington Disease, Epilepsy
INTRODUCTION
Huntington’s disease (HD) is a rare genetic disorder
that is inherited in an autosomal dominant pattern
often from the patients' paternal side. It is caused by
the expansion of a CAG trinucleotide repeat in the
HTT gene.1 This gene produces the Huntington
protein, which is thought to be important for basic
neuronal function. Patients with Juvenile Huntington’s
Disease (JHD) often have more than 60 trinucleotide
repeats rather than the normally expected 10–35
repeats. JHD is typically diagnosed when its onset is
before the age of 20 years old.2 The clinical course is
rapidly progressive, often with almost all patients only
surviving 10–15 years after the appearance of
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symptoms.3 JHD is characterized by bradykinesia,
rigidity, dystonia, tremors, myoclonus, slurred speech,
swallowing problems, and epilepsy.4 Seizures are
almost entirely limited to JHD in contrast to adult-
onset HD. Epilepsy seems to be more prevalent in
children who have symptoms before the age of 10
years old.5 Chorea is also generally absent to minimal
in JHD compared with adult-onset HD.5
Although seizures appear to be one of the main
symptoms of JHD, studies elaborating on details of
semiology, clinical course, and diagnostic studies are
few. Several years ago, a multicenter review by Cloud
et al. discussed 34 cases of genetically confirmed JHD
with reported seizures, but only 16 had accompanying
EEG data.6 Seizures also appear to be responsible for
more than 50% of hospitalizations of children with
JHD.7 There have been more recently reported cases
because of improvements in diagnostic technology
and clinical care leading to the expansion of available
knowledge of JHD and the features of accompanying
epilepsy. We describe a patient with refractory
epilepsy and his associated neuroimaging studies, EEG
findings, and antiseizure medications.
CASE PRESENTATION
A 9-year-old male first presented to the neurology
concussion clinic at the age of 4 years, a year after a
motor vehicle accident. During this accident, he was
not restrained in the car seat and sustained a
concussion. His family was not certain if he lost
consciousness during the accident. A brain magnetic
resonance imaging (MRI) scan at that time showed a
small cystic area with a fluid level and hemorrhages in
between the superior wall of the right maxillary sinus
and inferior wall of the right orbit, that were likely
related to the trauma. However, the brain parenchyma
structure was described as essentially normal. Several
months after the accident, his family reported some
nonspecific yet concerning symptoms, including being
offbalance, frequent falling, remarkable changes in his
mood, and overall easy fatigue and tiredness. He also
had trouble with small hand muscles` functions, such
as using a fork, knife, or spoon, and holding pens,
pencils, and crayons. He was referred to physical and
occupational therapy services accordingly. He showed
some clinical response after a few months of therapy
sessions, as he was able to run steadily, walk up, and
down stairs, use utensils appropriately, speak in
sentences, draw, and use pencils and crayons as
before. A follow-up brain MRI demonstrated a
resolving lesion along the roof of the right maxilla
sinus that likely represents a resolving hematoma.
Further updated brain MRI images revealed an
abnormal T2/FLAIR hyper intensity of the bilateral
caudate nuclei and putamina with volume loss, one of
the radiological signatures of JHD (Figs. 1–A&1–B).
Regarding his medical history, he was born at 35
weeks via spontaneous vaginal delivery without any
complications or time spent in the neonatal intensive
care unit. His list of medical problems includes balance
problems, developmental delay, eczema, epistaxis,
headache, mild intermittent asthma, and later post-
concussion syndrome. The patient father was
reported to have dementia and progressive cognitive
and motor decline; however, he did not have any
formal diagnosis of a precise neurological condition.
Further family history details were not available. Given
the various concerns and family history, the patient
underwent genetic testing. Molecular testing of exon
1 of the HIT gene showed 103 CAG repeats of full
penetrance consistent with JHD.
He presented to our emergency department at the
age of 9 years old because of numerous episodes of
generalized onset tonic-clonic seizures and severe
abdominal pain. Over a short period, he had increased
seizure frequency from weekly to every other day to
daily. The seizures were typically described as whole
body stiffening, then all extremities rhythmic shaking,
along with eye flickering that usually lasted for 1–
2 minutes. He also had focal onset seizures described
as raised bilateral upper extremity, eye deviation to
the left, left head torsion without full version, bilateral
tonic lower extremities, and rhythmic movements of
the mouth. There was no apnea, color changes, or
tongue biting.
Nevertheless, at times, he had urinary incontinence.
He was started on antiseizure medications, including
levetiracetam, oxcarbazepine, clobazam, and clona-
zepam as needed for spasms and prolonged seizures.
His physical exam was evolving with expressive and
receptive language delay (nonverbal), truncal hypo
tonicity, spastic extremities with cogwheel rigidity,
and worsening tremors in the upper extremities. His
EEG showed diffuse slowing and epileptiform
discharges consistent with mild diffuse encephalo-
pathy and occasional focal slowing in the left posterior
quadrant, indicating underlying focal neuronal dys-
function. His follow-up EEG showed rare and
independent spike and wave discharges over the
central and temporal regions suggesting cortical hyper
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excitability and an increased risk for focal onset
seizures (Fig. 2-A). It also showed rare bursts of
generalized sharp and slow-wave delta discharges
with bifrontal predominance, which suggested an
increased risk for generalized or focal onset seizure
with rapid generalization (Fig. 2–B). There was a
generalized background slowing with a posterior
dominant rhythm lower than expected for his age and
a poorly formed and sustained sleep architecture,
which suggested mild encephalopathy. A repeated
brain MRI demonstrated the slight interval pro-
gression of ex vacuo dilatation of the frontal horns.
Also, there was bifrontal periventricular hypo density
that was related to the known atrophy of the caudate
nuclei and putamina in line with JHD. With time, he
also began having frequent myoclonic seizures on a
daily basis. Therefore, oxcarbazepine was weaned
subsequently.
Apart from struggling with epilepsy control, he has
multiple other neurological issues, including severe
spasticity with developing contractures, a minimal
level of motor function, being wheelchair-bound,
slowly progressive swallowing dysfunction, complete
loss of vocalization, and continued loss of bowel and
bladder control. He also continued to have a variety of
almost constant abnormal movements, including
generalized bradykinesia, upper extremities tremors,
facial tic-like movement, and occasional dystonic
movements. This constellation of various movements
was only stopped during sleep. His family described
some choreiform movements, but it was felt that
these were minimal and rather infrequent.
He underwent a trial of tetrabenazine to relieve his
continuous movements, but the response was
minimal and complicated by a neuroleptic malignant
syndrome that led to discontinuing the medication.
DISCUSSION
HD is a degenerative neurological disorder due to
the expansion of a progressively abnormal CAG
trinucleotide repeat that results in the functional
decline across all domains and various movement
disorders.8 JHD is a severe subtype of HD with
childhood-onset. It has more severe CAG expansion
Figure 1-A: Coronal view T2/FLAIR MRI sequence demonstrating abnormal T2/FLAIR hyperintensities of the bilateral
caudate nuclei and putamina.
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and more burdens of neuropsychiatric
manifestations.9 Typically, patients have more than
60 CAG repeats, and the vast majority of cases are
paternally inherited. There is also growing and
accumulating evidence that children with more than
80 CAG repeats may constitute a distinct subgroup
of highly expanded genetic locus and have more
severe outcomes.10 Seizures seem to be a very
prominent clinical feature in JHD in contrast to
adult-onset HD.11
Figure 2-A: Interictal EEG showing bilateral independent epileptiform spike discharges from the right frontal, central, and
temporal areas.
Figure 1-B: Axial view T2/FLAIRMRI sequence demonstrating volume loss of the caudate nuclei bilaterally that resulted in
mild expansion of the frontal horns of the lateral ventricles bilaterally.
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Here, we presented a 9-year-old male with JHD and
early-onset refractory epilepsy. Although it is noted
that many patients with JHD have epilepsy, the exact
underlying neurophysiological mechanisms and etio-
logical pathways remain unclear. Older theories from
available neurophysiological studies suggested that
early neuronal cortical death is probably a contributing
factor.12 Primary neuronal degeneration and changes
in striatal synapses seem to be more noticeable in
children with early and severe clinical seizures.13 It
was noted in the available literature that younger age
at onset was related to more rapid disease progression
and shorter patient survival, which could also explain
the burden of our patient’s epilepsy.14 The age of
seizure onset appears to be a major factor regarding
the intractability and response to antiseizure
medications.15
The pathophysiology of seizures in JHD remains
unknown, especially concerning the age of presen-
tation and severity. We are uncertain if the motor
vehicle accident that he sustained at the age of three
might have exacerbated the rapid progression of our
patient’s JHD symptoms. Some epidemiological
studies have suggested that concussions or mild
traumatic brain injury (TBI) might be associated with a
twofold or greater increase in post-traumatic
epilepsy. However, a study involving 330 patients
determined that there was not an increase in the
incidence of epilepsy, and concussions and TBI should
not be considered significant risk factors for the first
5–10 years following the events.16
It is extremely challenging to locate precise epide-
miological data about genetically proven JHD since
only a handful of reported cases exist across the
globe. In the largest published report by Cloud and his
group, the prevalence of epilepsy was observed in
34% of patients in the JHD cohort. They concluded
that the most common seizure semiology was
generalized tonic seizures, followed by myoclonic, and
absence seizures.6 Our reported patient has a mix of
generalized tonic-clonic seizures, and unaware focal
seizure with secondary generalization, which is not a
seizure semiology that has been reported before in
JHD, to our knowledge.
Electroencephalogram (EEG) data in epileptic children
with JHD are sparse as well. EEG characteristics in
patients with adult-onset HD are mostly interictal
epileptiform discharges. Landau reported that inter-
ictal polyspike wave discharges were the most
common epileptiform finding in children with adoles-
cent-onset JHD.17 A couple of years later, Ullrich et al.
reported that generalized polyspike and slow-wave
complexes, spike, and slow-wave complexes, multi-
focal spikes, and focal spikes are the most commonly
observed EEG changes.18 In general, it seems that
children with JHD tend to have more generalized
spike-wave complexes with polyspikes being the
most common observation.17 Focal or multifocal EEG
discharges are less noted. Our patient’s EEG demon-
strated focal surface negative sharp waves that were
identified out of the left occipital (O1 electrode)
region throughout the study, with some field-effect
extending into the right occipital head region.
However, they were otherwise relatively restricted to
this focus. A subsequent EEG showed mild diffuse
slowing and disorganization of the background and
Figure 2-B: Interictal EEG showing runs of sharply contoured theta sharp waves and spikes in the bifrontal areas.
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occasional focal slowing in the left posterior quadrant.
His longer monitoring EEG in the epilepsy unit was
recently able to demonstrate rare and independent
spike and wave discharges over the central (Fz/
Cz.F7/FP2/F4/FP1/F3) and temporal (T6) regions,
which suggest cortical hyperexcitability and an
increased risk for focal onset seizures. This particular
video EEG also captured rare bursts of generalized
sharp and slow-wave delta discharges with bifrontal
predominance, which suggest an increased risk for
generalized onset seizures, or focal onset seizures
with rapid generalization (Figs. 2–A & 2–B).
In adulthood-onset HD, several neuroimaging
characteristics have been reported. In our patient, a
brain MRI obtained at the age of 8 years old showed
an abnormal T2/FLAIR hyper intensity of the bilateral
caudate nuclei and putamina with volume loss of the
caudate nuclei bilaterally. This volume loss resulted in
the mild expansion of the frontal horns of the lateral
ventricles bilaterally, which were thought to be
consistent with the diagnosis of JHD (Figs. 1–A &
1–B). His brain MR Spectroscopy demonstrated
normal metabolite patterns. Some reports described
brain MRIs that showed hyper intensity involving the
caudate nucleus and putamen on both sides19 Other
studies reported subcortical nonspecific T2 hyper
intense lesions, particularly in patients with the rigid,
more than the classical hyperkinetic form.20 Cerebral
volumetric loss has also been described in the basal
ganglia, thalami, hippocampi, substantia nigra, and
cerebellum with varying degrees of atrophy corre-
lating with the disease stage.21 Spectroscopy and
brain positron emission tomography scans might
provide a promising biomarker by enabling the early
detection of abnormal striatal glucose metabolism.22
Studies demonstrated that these neuroimaging
changes occurred before the emergence of clinical
symptoms.23 Nevertheless, not much is known about
typical MRI findings in JHD. One very recent cohort
suggested that MRI findings probably extend beyond
typical striatal structures as significant cerebellar
enlargement was discovered in the JHD cohort, which
may explain the observation of more hypokinetic
symptoms in children with JHD.24
Considering the rarity of available data, the unavail-
ability of consensus regarding seizure management in
JHD is not surprising. The most commonly used
antiseizure medications include sodium valproate,
followed by phenytoin, and carbamazepine.25 Other
less used therapies include clonazepam, phenobarbi-
tal, ethosuxamide, gabapentin, zonisamide, and
lamotrigine, among others.5 Although seizures appear
to be one of the major symptoms in JHD, most
patients are being managed with single monotherapy
agents. Intractable drug-resistant epilepsy is rather
rare in the cohort of patients with genetically proven
JHD. Our reported patient went through several
antiseizure medications until the combination of
oxcarbazepine, levetiracetam, and clobazam proved
to be the most successful and has been well-
tolerated.
CONCLUSIONS
JHD is a severe neurodegenerative brain disorder that
presents serious diagnostic challenges and manage-
ment limitations. Epilepsy is one of the major
neurological manifestations in JHD, but intractable
drug-resistant epilepsy is relatively rare. There are no
scientifically rigorous systematic reviews of epilepsy
characteristics, EEG features, imaging findings, and
evidence-based management strategies. This
reported case may provide insight into a unique
patient with JHD and refractory epilepsy. Our patient
demonstrated an early-onset clinical presentation,
focal EEG findings, and medication-resistant epilepsy,
which have not been extensively analyzed in this
population. It will be interesting to continue to learn
about how epilepsy in patients with JHD is being
addressed with the vast array of new antiepileptic
strategies being produced. Future reviews and
prospective studies will hopefully help to determine
which seizure management approach is best in this
vulnerable group of rare patients to help them
maintain the best possible quality of life. A major
limitation of our reported case is that he had a history
of TBI just before the emergence of his symptoms.
This confounding incident made the process of cross-
linking the clinical manifestations to the results of
diagnostic studies more challenging.
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